Olfr525 Inhibitors
Olfr525, a G protein-coupled receptor situated on olfactory sensory neurons, plays a vital role in the intricate process of olfactory signal transduction, contributing to the exquisite sensitivity and specificity exhibited by the sense of smell. Positioned on the membrane of olfactory sensory neurons, Olfr525 serves as a molecular switch, initiating a cascade of intracellular events upon binding to specific odor molecules, leading to the generation of neuronal signals and the perception of distinct smells. The functional significance of Olfr525 lies in its ability to decode chemical stimuli into biological responses, thus contributing to the intricate interplay of molecular events underlying olfaction.
The inhibition of Olfr525 involves a sophisticated array of mechanisms, incorporating both direct and indirect approaches. Direct inhibitors, such as Staurosporine, directly target the receptor, disrupting phosphorylation events and impeding the normal olfactory signal transduction process. Indirect inhibitors, exemplified by compounds affecting the PI3K or p38 MAPK pathways, modulate intracellular signaling dynamics, impacting olfactory receptor neuron function and hindering the activation of Olfr525. Calcium chelation, alteration of cAMP levels, and interference with vesicular dynamics further contribute to the repertoire of mechanisms employed for Olfr525 inhibition. Understanding these intricate processes provides valuable insights into the regulatory mechanisms governing olfactory responses, enhancing our comprehension of sensory biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Acts as a direct inhibitor of Olfr525 by targeting protein kinases. Staurosporine interferes with phosphorylation events, disrupting the olfactory signal transduction process and leading to the inhibition of Olfr525. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Targets the PI3K pathway to indirectly inhibit Olfr525. LY294002 modulates intracellular signaling, impacting olfactory receptor neuron function and hindering the activation of Olfr525. The inhibition is achieved through disruption of the phosphorylation cascades associated with PI3K signaling. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
Indirectly inhibits Olfr525 by targeting the epidermal growth factor receptor (EGFR) pathway. AG1478 disrupts downstream signaling, impacting olfactory receptor neuron function and suppressing the activation of Olfr525. The inhibition is achieved through interference with the phosphorylation cascades associated with EGFR signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Modulates Olfr525 indirectly by targeting the PI3K pathway. Wortmannin modifies intracellular signaling, impacting olfactory receptor neuron function and hindering the activation of Olfr525. The inhibition is achieved through disruption of the phosphorylation cascades associated with PI3K signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Targets the p38 MAPK pathway to indirectly inhibit Olfr525. SB203580 blocks phosphorylation cascades, disrupting downstream signaling and suppressing olfactory signal transduction. The inhibition is achieved by interfering with the normal activation events associated with the p38 MAPK pathway. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Indirectly inhibits Olfr525 by chelating intracellular calcium, modulating olfactory receptor neuron responses. BAPTA-AM alters the olfactory signal transduction process, leading to the suppression of Olfr525 activation. The inhibition is achieved through interference with intracellular calcium dynamics critical for olfactory signal transduction. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of endoplasmic reticulum (ER) Ca2+-ATPase, Thapsigargin directly affects Olfr525 activation. By disrupting ER calcium homeostasis, it interferes with the intracellular signaling required for normal olfactory signal transduction, leading to the inhibition of Olfr525. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Indirectly inhibits Olfr525 by targeting the extracellular signal-regulated kinase (ERK) pathway. PD98059 disrupts phosphorylation cascades, impacting olfactory receptor neuron function and suppressing the activation of Olfr525. The inhibition is achieved through interference with the normal activation events associated with the ERK pathway. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Affects Olfr525 indirectly by disrupting the Golgi apparatus function. Brefeldin A interferes with intracellular vesicle trafficking, impacting the normal localization of olfactory signal transduction components and suppressing the activation of Olfr525. The inhibition is achieved through interference with the vesicular dynamics critical for olfactory signal transduction. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
Targets phosphatidylcholine-specific phospholipase C (PC-PLC), influencing membrane lipid composition and indirectly inhibiting Olfr525. D609 alters the lipid microenvironment, impacting olfactory receptor neuron function and hindering the activation of Olfr525. The inhibition is achieved through interference with the lipid dynamics critical for olfactory signal transduction. | ||||||